IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+14.89%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$283M
AUM Growth
+$283M
Cap. Flow
+$47.2M
Cap. Flow %
16.65%
Top 10 Hldgs %
54.99%
Holding
128
New
25
Increased
11
Reduced
19
Closed
34

Top Buys

1
SLRN
ACELYRIN
SLRN
$61M
2
IDYA icon
IDEAYA Biosciences
IDYA
$11.5M
3
NUVL icon
Nuvalent
NUVL
$11.5M
4
IRON icon
Disc Medicine
IRON
$10.7M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
$8.56M

Top Sells

1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$13.5M
2
IMVT icon
Immunovant
IMVT
$12M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$7.66M
4
BLU
BELLUS Health Inc.
BLU
$6.37M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$5.19M

Sector Composition

1 Healthcare 97.66%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MGNX icon
101
MacroGenics
MGNX
$121M
– –
-250,000
Closed -$1.79M
KRYS icon
102
Krystal Biotech
KRYS
$4.35B
– –
0
– –
IVA
103
Inventiva
IVA
$802M
– –
-292,599
Closed -$999K
IMVT icon
104
Immunovant
IMVT
$2.91B
– –
-774,398
Closed -$12M
GOSS icon
105
Gossamer Bio
GOSS
$587M
– –
-6,100
Closed -$7.69K
GNFT
106
Genfit
GNFT
$198M
– –
-32,786
Closed -$132K
REPL icon
107
Replimune Group
REPL
$460M
– –
0
– –
SAGE
108
DELISTED
Sage Therapeutics
SAGE
– –
-17,805
Closed -$747K
SRPT icon
109
Sarepta Therapeutics
SRPT
$1.98B
– –
-8,324
Closed -$1.15M
ACAD icon
110
Acadia Pharmaceuticals
ACAD
$4.34B
– –
-60,000
Closed -$1.13M
ACHV icon
111
Achieve Life Sciences
ACHV
$146M
– –
-174,714
Closed -$990K
AKRO icon
112
Akero Therapeutics
AKRO
$3.65B
– –
-50,000
Closed -$1.91M
ALT icon
113
Altimmune
ALT
$325M
– –
-677,300
Closed -$2.86M
AMLX icon
114
Amylyx Pharmaceuticals
AMLX
$877M
– –
-10,000
Closed -$293K
ARGX icon
115
argenx
ARGX
$44.2B
– –
0
– –
ARKG icon
116
ARK Genomic Revolution ETF
ARKG
$1.05B
– –
-46,462
Closed -$1.4M
ARKK icon
117
ARK Innovation ETF
ARKK
$7.43B
– –
-4,519
Closed -$182K
JBIO
118
Jade Biosciences, Inc. Common Stock
JBIO
$245M
– –
-195,146
Closed -$3.94M
AXSM icon
119
Axsome Therapeutics
AXSM
$6.09B
– –
0
– –
AZN icon
120
AstraZeneca
AZN
$255B
– –
0
– –
BIIB icon
121
Biogen
BIIB
$20.8B
– –
-962
Closed -$267K
BMRN icon
122
BioMarin Pharmaceuticals
BMRN
$11.3B
– –
-50,000
Closed -$4.86M
BTAI icon
123
BioXcel Therapeutics
BTAI
$52.7M
– –
-133,014
Closed -$2.48M
CLDX icon
124
Celldex Therapeutics
CLDX
$1.57B
– –
-106,057
Closed -$3.82M
CRSP icon
125
CRISPR Therapeutics
CRSP
$4.82B
– –
0
– –
2 3 4
5
6